These include the presence of inflammatory mediators within the tumor microenvironment [17], the loss of phosphatase and tensin homologue (PTEN), a negative regulator of PI3K activation [18], and cancer cell proliferation [19]. This evidence concerns the gene PTEN and neoplasm.